Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

925 publication(s) found matching the search criteria

Long COVID and pituitary dysfunctions: a bidirectional relationship?


Author(s): di Filippo L, Franzese V, Santoro S, Doga M, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Pituitary adenoma
Publication: Pituitary v27.6 p955-969 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s11102-024-01442-8 Keywords: Adrenal insufficiency,COVID-19,Growth hormone deficiency,Hypogonadism,Hypopituitarism,Long COVID,Pituitary,SARS-CoV-2
MTG6

Modern approach to bone comorbidity in prolactinoma


Author(s): Uygur MM, Menotti S, Santoro S, Giustina A
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Prolactinoma
Publication: Pituitary v27.6 p802-812 Year: 2024 ORPHAcode / other: ORPHA2965
DOI: 10.1007/s11102-024-01469-x Keywords: Bone mineral density,Bone quality,Dopamine agonist,Hypogonadism,PTCOEs,Prolactinoma,Vertebral fractures
MTG6

Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors


Author(s): Jotanovic J, Boldt HB, Burton M, Andersen MS, Bengtsson D, Bontell TO, Ekman B, Engström BE, Feldt-Rasmussen U, Heck A, Jakovcevic A, Jørgensen JOL, Kraljevic I, Kunicki J, Lindsay JR, Losa M, Loughrey PB, Maiter D, Maksymowicz M, Manojlovic-Gacic E, Pahnke J, Petersenn S, Petersson M, Popovic V, Ragnarsson O, Rasmussen ÃK, Reisz Z, Saeger W, Schalin-Jäntti C, Scheie D, Terreni MR, Tynninen O, Whitelaw B, Burman P, Casar-Borota O
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Odense University Hospital ; Sahlgrenska University Hospital ; Helsinki University Hospital (HUS) ; Oslo University Hospital ; San Raffaele hospital - Milan ; Sestre milosrdnice University Hospital Center ;
Condition / Disease: Pituitary adenoma
Publication: Acta Neuropathologica v148.1 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s00401-024-02836-5 Keywords: Aggressive pituitary tumor,Methylation analysis,Pituitary adenoma,Pituitary carcinoma,Pituitary neuroendocrine tumor
MTG6

Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls


Author(s): Glintborg D, Møller JK, Rubin KH, Lidegaard Ã, T’Sjoen G, Larsen MJÃ, Hilden M, Andersen MS
Affiliated Institution / ERN: Ghent University Hospital ; Odense University Hospital ; Copenhagen University Hospital, Rigshospitalet ;
Condition / Disease: Transgender, female to male
Publication: The Journal of Clinical Endocrinology & Metabolism v109.12 p3076-3086 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1210/clinem/dgae351 Keywords: gender-affirming hormone,medicine prescription,mental health,register-based,socioeconomic status,transgender
MTG7

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases


Author(s): Araujo-Castro M, Biagetti B, Menéndez Torre E, Novoa-Testa I, Cordido F, Pascual Corrales E, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Percovich JC, García Centeno R, González L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar R, Bernabéu I, Alvarez-Escola C, Benítez Valderrama P, Tenorio-Jimenéz C, Abellán Galiana P, Venegas Moreno E, González Molero I, Iglesias P, Blanco C, Vidal-Ostos De Lara F, de Miguel P, López Mezquita E, Hanzu F, Aldecoa I, Lamas C, Aznar S, Aulinas A, Calabrese A, Gracia P, Recio-Córdova JM, Aviles M, Asensio-Wandosel D, Sampedro M, Ruz-Caracuel I, Camara R, Paja M, Fajardo-Montañana C, Marazuela M, Puig-Domingo M
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ; Complejo Hospitalario Regional Virgen del Rocio ;
Condition / Disease: Acromegaly
Publication: The Journal of Clinical Endocrinology & Metabolism v109.12 pe2178-e2187 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1210/clinem/dgae126 Keywords: acromegaly,mixed tumors,pituitary adenoma,prolactin,surgical remission
MTG6

Delineating the Psychiatric Morbidity Spectrum in Congenital Adrenal Hyperplasia: A Population-based Registry Study


Author(s): Lind-Holst M, Hansen D, Main KM, Juul A, Andersen MS, Dunø M, Rasmussen ÃK, Jørgensen N, Gravholt CH, Berglund A
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Aarhus University Hospital ; Odense University Hospital ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Journal of Clinical Endocrinology & Metabolism doi:10.1210/clinem/dgae780 Year: 2024 ORPHAcode / other: ORPHA418
DOI: 10.1210/clinem/dgae780 Keywords: congenital adrenal hyperplasia,population-based,psychiatry
MTG7

Genotype-phenotype correlation and feminizing surgery in Danish children with congenital adrenal hyperplasia


Author(s): Lind-Holst M, Berglund A, Duno M, Hvistendahl G, Fossum M, Juul A, Jørgensen N, Main KM, Gravholt CH, Hansen D
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Aarhus University Hospital ; Odense University Hospital ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Hormone Research in Paediatrics p1-20 Year: 2024 ORPHAcode / other: ORPHA418
DOI: 10.1159/000541775 Keywords:
MTG7

Who and how to screen for endogenous hypercortisolism in patients with mood disorders


Author(s): Ferrante E, Simeoli C, Mantovani G, Pivonello R
Affiliated Institution / ERN: AOU Federico II - Naples ; Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease: Cushing disease
Publication: Journal of Endocrinological Investigation doi:10.1007/s40618-024-02457-5 Year: 2024 ORPHAcode / other: ORPHA96253
DOI: 10.1007/s40618-024-02457-5. Keywords: Cushing’s syndrome,Depression,Mood disorders,Non-neoplastic hypercortisolism
MTG6

Who and how to screen for endogenous hypercortisolism in patients with mood disorders


Author(s): Ferrante E, Simeoli C, Mantovani G, Pivonello R
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AOU Federico II - Naples ;
Condition / Disease: Cushing disease
Publication: Journal of Endocrinological Investigation doi:10.1007/s40618-024-02457-5 Year: 2024 ORPHAcode / other: ORPHA96253
DOI: 10.1007/s40618-024-02457-5 Keywords: Cushing’s syndrome,Depression,Mood disorders,Non-neoplastic hypercortisolism
MTG6

Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world DPV registry


Author(s): Lanzinger S, Laubner K, Warncke K, Mader JK, Kummer S, Boettcher C, Biester T, Galler A, Klose D, Holl RW
Affiliated Institution / ERN: Hannoversche Kinderheilanstalt ;
Condition / Disease: Diabetes mellitus
Publication: Journal of Diabetes v16.11 Year: 2024 ORPHAcode / other: ORPHA101952
DOI: 10.1111/1753-0407.70028 Keywords: MODY,diabetes prospective follow‐up (DPV) registry,monogenic diabetes,oral antidiabetic drugs,real‐world data
MTG3

The Definition of Recurrence of Differentiated Thyroid Cancer: A Systematic Review of the Literature


Author(s): van de Berg DJ, Rodriguez Schaap PM, Jamaludin FS, van Santen HM, Clement SC, Vriens MR, van Trotsenburg ASP, Mooij CF, Bruinstroop E, Kruijff S, Peeters RP, Verburg FA, Netea-Maier RT, Nieveen van Dijkum EJM, Derikx JPM, Engelsman AF
Affiliated Institution / ERN: University Medical Center Groningen ; Institute of Oncology “Prof dr. Ion Chiricuta” CLUJ NAPOCA ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Thyroid® v34.11 p1324-1334 Year: 2024 ORPHAcode / other: ORPHA146
DOI: 10.1089/thy.2024.0271 Keywords: definition,differentiated thyroid carcinoma,persistent disease,recurrence
MTG8

Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings


Author(s): Kelly AS, Bahlke M, Baker JL, de Beaufort C, Belin RM, Fonseca H, Hale PM, Holm J, Hsia DS, Jastreboff AM, Juliusson PB, Murphy M, Pak J, Paul E, Rudolph B, Srivastava G, Tornøe CW, Weghuber D, Fox CK
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ; Copenhagen University Hospital, Rigshospitalet ; Bergen Hospital Trust ;
Condition / Disease: Melanocortin 4 receptor deficiency
Publication: Pediatric Obesity v19.11 Year: 2024 ORPHAcode / other: ORPHA71529
DOI: 10.1111/ijpo.13161 Keywords: anti‐obesity medication,clinical trials,obesity,pediatric,pharmacotherapy
MTG6

Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R Gene


Author(s): Vimercati A, Tannorella P, Guzzetti S, Calzari L, Gentilini D, Manfredini E, Gori G, Gaudino R, Antona V, Piccione M, Daolio C, Auricchio R, Sirchia F, Minelli A, Rossi E, Bellini M, Biasucci G, Raucci AR, Pozzobon G, Patti G, Napoli F, Larizza L, Maghnie M, Russo S
Affiliated Institution / ERN: AOUI Verona ; IRCCS Auxologico Italian Institute - Milan ; IRCCS Istituto Giannina Gaslini, Genova ; Meyer Children’s Hospital Florence ;
Condition / Disease: Silver-Russell Syndrome
Publication: The Journal of Clinical Endocrinology & Metabolism doi:10.1210/clinem/dgae730 Year: 2024 ORPHAcode / other: ORPHA813
DOI: 10.1210/clinem/dgae730 Keywords: IGF1R,IGF2-PLAG1-HMGA2 axis,(epi)genetic phenotype,Silver-Russell syndrome,body asymmetry,familial cases
MTG5

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study


Author(s): Valdés N, Romero A, Diego E, Calatayud M, Lamas C, Araujo-Castro M, Álvarez-Escolá C, Díaz JA, Alcázar V, Sastre J, Martínez R, Oriola J, Paja M, Sánchez-Sobrino P, Salinas I, Recio-Córdova JM, Navarro E, Chiara MD, Castaño L, Casterás A
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ; Hospital Universitario Cruces ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA652
DOI: 10.3389/fendo.2024.1427821 Keywords: Multiple Endocrine Neoplasia type 1,macroadenomas,microadenomas,non-functioning pituitary adenomas,outcomes,pituitary adenomas,progression,prolactinomas
MTG4 MTG6

Areas of uncertainty on the diagnosis, treatment, and follow-up of hypophosphatemia in adults: an Italian Delphi consensus


Author(s): Chiodini I, d’Angela D, Falchetti A, Gennari L, Malavolta N, Masi L, Migliore A, Orso M, Polistena B, Rendina D, Scillitani A, Spandonaro F, Vezzoli G, Vescini F, Ambrosio MR, Cairoli E, Camozzi V, Cannavò S, Eller-Vainicher C, Gianninir S, Gianotti L, Giusti A, Merlotti D, Migliaccio S, Minisola S, Montinaro V, Palermo A, Pasquali D, Passeri G, Procopio M, Salcuni AS
Affiliated Institution / ERN: AOU University of Campania "Luigi Vanvitelli", Naples ; San Raffaele hospital - Milan ;
Condition / Disease: X-linked hypophosphataemia
Publication: Journal of Endocrinological Investigation v48.2 p257-267 Year: 2024 ORPHAcode / other: ORPHA89936
DOI: 10.1007/s40618-024-02458-4 Keywords:
MTG2

Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis


Author(s): Tienforti D, Marinelli L, Vervalcke J, Spagnolo L, Antolini F, Bichiri A, Baroni MG, Motta G, T’Sjoen G, Barbonetti A
Affiliated Institution / ERN: Ghent University Hospital ; AO City of Health and Science - Turin ;
Condition / Disease: Transgender, female to male
Publication: Calcified Tissue International v115.5 p624-635 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1007/s00223-024-01296-z Keywords: BMD,Bone turnover markers,GAHT,Gender incongruence,Testosterone,Transmen
MTG7

The effects of gender-affirming testosterone therapy in transgender men on the development of acne, acne severity and the relationship with clinical parameters: a three-year follow-up study


Author(s): Madsen MC, Berg JN, Fisher AD, T’Sjoen G, Rustemeyer T, Den Heijer M, Wiepjes CM, Dreijerink KM
Affiliated Institution / ERN: Ghent University Hospital ; Amsterdam UMC ; University Hospital Florence ;
Condition / Disease: Transgender, female to male
Publication: European Journal of Dermatology v34.5 p497-501 Year: 2024 ORPHAcode / other: ICD-10 F64
DOI: 10.1684/ejd.2024.4758 Keywords: acne,gender dysphoria,gender-affirming hormone therapy,testosterone,transgender
MTG7

Why and how optical molecular imaging should further be catalyzed by nuclear medicine and molecular imaging: report from the EANM piloting group


Author(s): Vonk J, Dierckx RA, Keereweer S, Vahrmeijer A, Verburg F, Kruijff S
Affiliated Institution / ERN: University Medical Center Groningen ; Karolinska University Hospital ;
Condition / Disease: Follicular thyroid carcinoma
Publication: European Journal of Nuclear Medicine and Molecular Imaging v51.12 p3501-3504 Year: 2024 ORPHAcode / other: ORPHA146
DOI: 10.1007/s00259-024-06729-3 Keywords:
MTG8

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly


Author(s): Pascual-Corrales E, Biagetti B, Marazuela M, Asensio-Wandosel D, Rodríguez Berrocal V, Irigaray Echarri A, Novo-Rodríguez C, Calatayud M, Bernabéu I, Alvarez-Escola C, Tenorio-Jiménez C, González Molero I, Iglesias P, Blanco C, de Miguel P, López Mezquita E, Lamas C, Aulinas A, Gracia P, Recio-Córdova JM, Sampedro-Nuñez M, Paja M, Moure Rodríguez MD, Fajardo-Montañana C, Cordido F, Menéndez Torre E, Percovich JC, García-Centeno R, Cámara R, Hanzu FA, Vicente Delgado A, González Fernández L, Guerrero-Pérez F, Ollero García-Agulló MD, Novoa-Testa I, Villar-Taibo R, Benítez Valderrama P, Abellán Galiana P, Venegas Moreno E, Vidal-Ostos De Lara F, Enseñat J, Aznar S, Asla Q, Aviles-Pérez MD, Puig-Domingo M, Araujo-Castro M
Affiliated Institution / ERN: Hospital de la Santa Creu i Sant Pau ; Hospital Universitari Vall d’Hebron ;
Condition / Disease: Acromegaly
Publication: Pituitary v27.5 p497-506 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1007/s11102-024-01415-x Keywords:
MTG6

Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database


Author(s): Marini F, Marcucci G, Giusti F, Arvat E, Benvenga S, Bondanelli M, Castellino L, Camozzi V, Corbetta S, Davì MV, Famà F, Ferone D, Iacobone M, Loli P, Mantovani G, Pagotto U, Persani L, Perigli G, Piovesan A, Repaci A, Ruggeri RM, Eller-Vainicher C, Vera L, Zatelli MC, Zavatta G, Brandi ML
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; University Hospital Florence ; San Raffaele hospital - Milan ; AOU - Ferrara ; AOU polyclinic "G.Martino" of Messina ; University Hospital of Padova ; AOU-Bologna ; IRCCS Ospedale Policlinico San Martino – Genova ;
Condition / Disease: Parathyroid carcinoma
Publication: European Journal of Endocrinology v191.4 p416-425 Year: 2024 ORPHAcode / other: ORPHA143
DOI: 10.1093/ejendo/lvae121 Keywords:
MTG2

Policy for transitioning childhood-onset growth hormone deficiency from pediatric to adult endocrine care in Belgium


Author(s): Staels W, De Schepper J, Becker M, Lysy P, Klink D, Logghe K, den Brinker M, Rochtus A, Lapauw B, Cools M, Alexopoulou O, Bex M, Corvilain B, Crenier L, De Block C, Donckier J, Hilbrands R, Ponchon M, T'Sjoen G, Van Den Bruel A, Vandewalle S, Velkeniers B
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ; University Hospitals Saint-Luc ; UZ Brussels ; UZ Antwerpen ; UZ Leuven ;
Condition / Disease: Acquired pituitary hormone deficiency
Publication: Frontiers in Endocrinology v15 Year: 2024 ORPHAcode / other: ORPHA95502
DOI: 10.3389/fendo.2024.1459998 Keywords: growth hormone deficiency (GHD),growth hormone stimulation tests,growth hormone therapy,policy for transition care,transition
MTG6

Diagnosis and management of pituitary adenomas in children and adolescents


Author(s): Maiter D, Chanson P, Constantinescu SM, Linglart A
Affiliated Institution / ERN: University Hospitals Saint-Luc ; Hôpital Bicêtre ;
Condition / Disease: Pituitary adenoma
Publication: European Journal of Endocrinology v191.4 pR55-R69 Year: 2024 ORPHAcode / other: ORPHA99408
DOI: 10.1093/ejendo/lvae120 Keywords:
MTG6

Relacorilant or surgery improved hemostatic markers in Cushing syndrome


Author(s): Simeoli C, Di Paola N, Stigliano A, Lardo P, Kearney T, Mezosi E, Ghigo E, Giordano R, Mariash CN, Donegan DM, Feelders RA, Hand AL, Araque KA, Moraitis AG, Pivonello R
Affiliated Institution / ERN: AOU Federico II - Naples ; Erasmus MC: University Medical Center Rotterdam ; AO City of Health and Science - Turin ;
Condition / Disease: Cushing syndrome due to cortisol-producing adrenocortical adenoma
Publication: Journal of Endocrinological Investigation doi:10.1007/s40618-024-02468-2 Year: 2024 ORPHAcode / other: ORPHA647758
DOI: 10.1007/s40618-024-02468-2 Keywords: Coagulation factor,Cushing syndrome,Hypercoagulable state,Relacorilant,Surgery
MTG1

Genetic and Functional Studies of Patients with Thyroid Dyshormonogenesis and Defects in the TSH Receptor (TSHR)


Author(s): Yeste D, Baz-Redón N, Antolín M, Garcia-Arumí E, Mogas E, Campos-Martorell A, González-Llorens N, Aguilar-Riera C, Soler-Colomer L, Clemente M, Fernández-Cancio M, Camats-Tarruella N
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Familial hyperthyroidism due to mutations in TSH receptor
Publication: International Journal of Molecular Sciences v25.18 p10032 Year: 2024 ORPHAcode / other: ORPHA424
DOI: 10.3390/ijms251810032 Keywords: TSH receptor,TSHR,congenital hypothyroidism,functional studies,genetic variants,thyroid dyshormonogenesis,thyroid gland
MTG8

Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus


Author(s): Daly AF, Dunnington LA, Rodriguez-Buritica DF, Spiegel E, Brancati F, Mantovani G, Rawal VM, Faucz FR, Hijazi H, Caberg J, Nardone AM, Bengala M, Fortugno P, Del Sindaco G, Ragonese M, Gould H, Cannavò S, Pétrossians P, Lania A, Lupski JR, Beckers A, Stratakis CA, Levy B, Trivellin G, Franke M
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; University Hospital Liège ;
Condition / Disease: Acromegaly
Publication: Genome Medicine v16.1 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1186/s13073-024-01378-5 Keywords: 4C,Chromosome microarray,Enhancer,GPR101,HiC,Neo-TAD,Pituitary tumor,Prenatal diagnosis,Topologically associating domains,X-linked acrogigantism
MTG6

Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management


Author(s): Esposito D, Boguszewski CL, Colao A, Fleseriu M, Gatto F, Jørgensen JOL, Ragnarsson O, Ferone D, Johannsson G
Affiliated Institution / ERN: AOU Federico II - Naples ; Sahlgrenska University Hospital ; Aarhus University Hospital ;
Condition / Disease: Acromegaly
Publication: Nature Reviews Endocrinology v20.9 p541-552 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1038/s41574-024-00993-x Keywords:
MTG6

Antibodies Against ZSCAN1 in Pediatric and Adult Patients With Non-Paraneoplastic ROHHAD Syndrome


Author(s): Serafim AB, Olivé-Cirera G, Ortega-González Ã, Kruer MC, Weese-Mayer D, Rand CM, Fons C, Fernández-Ramos JA, Clemente M, Simabukuro MM, Embiruçu EK, Ibáñez-Micó S, Dalmau JO, Graus F, Armangué T, Sabater L
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ; Sant Joan de Déu Hospital ;
Condition / Disease: ROHHAD syndrome
Publication: Neurology Neuroimmunology & Neuroinflammation v11.5 Year: 2024 ORPHAcode / other: ORPHA293987
DOI: 10.1212/NXI.0000000000200276 Keywords:
MTG6

Collection on clinical photoacoustic imaging


Author(s): Vonk J, Knieling F, Kruijff S
Affiliated Institution / ERN: University Medical Center Groningen ; Charité Universitätsmedizin Berlin ;
Condition / Disease: Follicular thyroid carcinoma
Publication: European Journal of Nuclear Medicine and Molecular Imaging v51.11 p3151-3152 Year: 2024 ORPHAcode / other: ORPHA146
DOI: 10.1007/s00259-024-06780-0 Keywords:
MTG8

Acromegaly management in the Nordic countries: A Delphi consensus survey


Author(s): Arlien‐Søborg MC, Dal J, Heck A, Stochholm K, Husted E, Feltoft CL, Rasmussen ÃK, Feldt‐Rasmussen U, Andreassen M, Klose MC, Nielsen TL, Andersen MS, Christensen LL, Krogh J, Jarlov A, Bollerslev J, Nermoen I, Oksnes M, Dahlqvist P, Olsson T, Berinder K, Hoybye C, Petersson M, Akerman A, Wahlberg J, Ekman B, Engstrom BE, Johannsson G, Ragnarsson O, Olsson D, Sigurjónsdóttir HÃ, Fougner SL, Matikainen N, Vehkavaara S, Metso S, Jaatinen P, Hämäläinen P, Rintamäki R, Yliaska I, Immonen H, Mäkimattila S, Cederberg‐Tamminen H, Viukari M, Nevalainen P, Nuutila P, Schalin‐Jäntti C, Burman P, Jørgensen JOL
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Oslo University Hospital ; Sahlgrenska University Hospital ;
Condition / Disease: Acromegaly
Publication: Clinical Endocrinology v101.3 p263-273 Year: 2024 ORPHAcode / other: ORPHA963
DOI: 10.1111/cen.15095 Keywords: Delphi,acromegaly,dopamine agonist,growth hormone,growth hormone receptor antagonist,insulin‐like growth factor i,somatostatin
MTG6

FOVEA PLANA AND FUNDUS HYPOPIGMENTATION IN PRADER–WILLI SYNDROME


Author(s): de Laage de Meux P, Mosbah H, Cotton-Viard A, Cohen SY
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Prader-Willi syndrome
Publication: RETINAL Cases & Brief Reports v18.5 p647-650 Year: 2024 ORPHAcode / other: ORPHA739
DOI: 10.1097/icb.0000000000001441 Keywords:
MTG5
Page 2 of 31«12345...102030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance